Physician profile
Dawn L Sadowski
NPI 1396743647
$3,204.70
in general payments reported to CMS, 2019-2025
28 companies · $620 in 2025
The $620 reported for 2025 was more than what 85% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $161 · 2021: $464 · 2022: $649 · 2023: $479 · 2024: $529 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,627.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $418.72 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima, Myosure Tissue Removal Device |
| Amgen INC. | $320.05 | 2019-2025 | Evenity, Prolia, Prolia |
| Abbvie INC. | $314.27 | 2019-2023 | Lo Loestrin Fe |
| Sumitomo Pharma America, INC. | $299.75 | 2023-2025 | Myfembree |
| Therapeuticsmd, INC. | $268.26 | 2019-2022 | |
| Aspira Women'S Health INC | $237.60 | 2022 | |
| Shield Therapeutics INC | $152.42 | 2023-2024 | Accrufer |
| Mayne Pharma Commercial LLC | $143.90 | 2022-2025 | |
| Pfizer INC. | $127.03 | 2019-2023 | |
| Astellas Pharma US INC | $124.07 | 2022-2025 | Veozah |
| Organon LLC | $111.94 | 2024-2025 | Nexplanon |
| Exeltis, USA INC. | $75.26 | 2023-2025 | Slynd |
| Lilly USA, LLC | $70.08 | 2021-2025 | Zepbound, Mounjaro |
| Coopersurgical, INC. | $66.81 | 2019-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $66.74 | 2022 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $64.67 | 2025 | Zurzuvae |
| Myovant Sciences INC. | $53.66 | 2022 | |
| Becton, Dickinson and Company | $51.84 | 2021-2023 | Bd Onclarity |
| Amag Pharmaceuticals, INC. | $49.94 | 2019 | |
| Merck Sharp & Dohme LLC | $30.13 | 2020 | |
| Minerva Surgical, INC | $27.22 | 2021-2023 | |
| Avion Pharmaceuticals | $26.08 | 2020-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.24 | 2025 | |
| Exact Sciences Corporation | $20.30 | 2023 | Cologuard Collection Kit |
| Lupin INC. | $19.27 | 2021 | |
| Scynexis, INC. | $18.97 | 2022 | |
| Acessa Health INC. | $12.05 | 2019 | |
| Tactile Systems Technology INC | $11.43 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dawn Sadowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.